On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Fabry disease
- Metabolic defect - accumulation of GL-3
- GL-3 deposits in vascular endothelium
- Progression in affected males
- Inheritance
- Progression in affected females
- Multisystemic manifestations
- Angiokeratomas
- Corneal whorls
- Diagnosis of Fabry disease
- Differential diagnosis
- Classical presentation Fabry disease
- Classical presentation - MRI
- Classical presentation - kidney biopsy (1)
- Classical presentation - kidney biopsy (2)
- Zebra bodies
- Zebra bodies in EM
- Less severe presentation in an older brother
- Renal biopsy findings
- Involvement of tubules
- Zebra bodies in kidney glomerulus
- Heavy dense deposits in EM
- Fabry disease: affected females
- Foamy cytoplasmic inclusion
- Foamy cytoplasmic inclusion - higher power view
- Cardiac involvement (1)
- Cardiac involvement (2)
- Cardiac involvement (3)
- Summary of kidney pathology
- Treatment of Fabry disease with renal involvement
- Renal transplant
- Enzyme therapy in transplant
- End stage renal disease in Fabry
- Patient survival on dialysis
- Enzyme therapy in dialysis
- Enzyme replacement therapy - drugs
- ERT - trials
- Phase 3 - complete endothelial clearance
- GL-3 cleared from kidney
- ERT (1)
- ERT (2)
- Similarities of Fabry disease and diabetes
- Fabry and diabetic nephropathy - management
- Fabry disease - conclusions
Topics Covered
- Diagnosis of Fabry disease
- Metabolic defect: GL-3 accumulation
- Multi-systemic manifestations
- Case examples
- Kidney pathology in Fabry disease
- Enzyme therapy
- Dialysis and transplantation
- Analogy to diabetic nephropathy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Warnock, D. (2007, October 1). Fabry disease: alfa-galactosidase A deficiency and enzyme replacement therapy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/IYBN9461.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. David Warnock has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide